$CLRO
CLEARONE INC Stock $clro

$clro Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000175392620000379 Filed on November 16, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$8.570M	$8.412M	$5.992M
YoY Change	35.39%	40.39%	-10.34%
Cost Of Revenue	$4.980M	$4.892M	$3.455M
YoY Change	50.45%	41.59%	-6.7%
Gross Profit	$3.580M	$3.520M	$2.537M
YoY Change	18.94%	38.75%	-14.87%
Gross Profit Margin	41.77%	41.84%	42.34%
Selling, General & Admin	$3.210M	$3.179M	$3.207M
YoY Change	-9.07%	-0.87%	-8.61%
% of Gross Profit	89.66%	90.31%	126.41%
Research & Development	$1.190M	$1.501M	$1.428M
YoY Change	-17.93%	5.11%	-19.82%
% of Gross Profit	33.24%	42.64%	56.29%
Depreciation & Amortization	$630.0K	$600.0K	$490.0K
YoY Change	36.96%	22.45%	22.5%
% of Gross Profit	17.6%	17.05%	19.31%
Operating Expenses	$4.400M	$4.680M	$4.635M
YoY Change	-11.65%	0.97%	-12.38%
Operating Profit	-$820.0K	-$1.160M	-$2.098M
YoY Change	-58.38%	-44.71%	-9.18%
Interest Expense	-$110.0K	$108.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$10.00K	$19.00K	$142.0K
YoY Change	-133.33%	-86.62%	2740.0%
Pretax Income	-$920.0K	-$1.249M	-$1.956M
YoY Change	-53.77%	-36.15%	-15.14%
Income Tax	-$3.750M	$11.00K	$20.00K
% Of Pretax Income
Net Earnings	$5.550M	-$1.260M	-$1.976M
YoY Change	-378.89%	-36.23%	-80.52%
Net Earnings / Revenue	64.76%	-14.98%	-32.98%
Basic Earnings Per Share		-$0.07	-$0.12
Diluted Earnings Per Share	$292.1K	-$0.07	-$0.12
COMMON SHARES
Basic Shares Outstanding	18.77M shares	17.00M shares	16.65M shares
Diluted Shares Outstanding		17.00M shares	16.65M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.682M	$7.210M	$3.650M
YoY Change	-5.75%	97.53%	-18.71%
Cash & Equivalents	$3.803M	$5.583M	$2.010M
Short-Term Investments	$2.879M	$1.620M	$1.640M
Other Short-Term Assets	$1.540M	$2.180M	$5.640M
YoY Change	30.51%	-61.35%	122.92%
Inventory	$10.46M	$7.838M	$11.69M
Prepaid Expenses
Receivables	$5.194M	$6.705M	$6.319M
Other Receivables	$7.170M	$0.00	$0.00
Total Short-Term Assets	$29.28M	$23.93M	$27.30M
YoY Change	16.28%	-12.33%	6.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$906.0K	$995.0K	$1.099M
YoY Change	-13.22%	-9.46%	-24.26%
Goodwill
YoY Change
Intangibles	$19.25M	$18.49M	$12.61M
YoY Change	37.4%	46.67%	33.88%
Long-Term Investments	$1.760M	$1.390M	$2.240M
YoY Change	15.79%	-37.95%	-61.11%
Other Assets	$4.599M	$4.596M	$197.0K
YoY Change	-0.33%	2232.99%	-47.75%
Total Long-Term Assets	$33.04M	$33.84M	$25.84M
YoY Change	10.41%	30.97%	2.25%
TOTAL ASSETS
Total Short-Term Assets	$29.28M	$23.93M	$27.30M
Total Long-Term Assets	$33.04M	$33.84M	$25.84M
Total Assets	$62.32M	$57.77M	$53.13M
YoY Change	13.09%	8.73%	4.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.950M	$4.355M	$1.735M
YoY Change	37.58%	151.01%	-48.42%
Accrued Expenses	$2.352M	$3.405M	$2.864M
YoY Change	-26.61%	18.89%	71.7%
Deferred Revenue	$123.0K		$227.0K
YoY Change	-28.9%		-9.2%
Short-Term Debt	$672.0K	$395.0K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.097M	$8.314M	$4.826M
YoY Change	13.57%	72.28%	-8.63%
LONG-TERM LIABILITIES
Long-Term Debt	$3.245M	$3.470M	$0.00
YoY Change	46.04%
Other Long-Term Liabilities	$678.0K	$111.0K	$195.0K
YoY Change	384.29%	-43.08%	-69.81%
Total Long-Term Liabilities	$3.923M	$111.0K	$195.0K
YoY Change	66.09%	-43.08%	-69.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.097M	$8.314M	$4.826M
Total Long-Term Liabilities	$3.923M	$111.0K	$195.0K
Total Liabilities	$12.51M	$13.52M	$7.150M
YoY Change	17.65%	89.12%	17.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.38M	-$18.93M	-$11.90M
YoY Change	-3.64%	59.08%	304.83%
Common Stock	$63.38M	$63.37M	$58.05M
YoY Change	8.27%	9.15%	21.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$49.81M	$44.25M	$45.98M
YoY Change
Total Liabilities & Shareholders Equity	$62.32M	$57.77M	$53.13M
YoY Change	13.09%	8.73%	4.6%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	$5.550M	-$1.260M	-$1.976M
YoY Change	-378.89%	-36.23%	-80.52%
Depreciation, Depletion And Amortization	$630.0K	$600.0K	$490.0K
YoY Change	36.96%	22.45%	22.5%
Cash From Operating Activities	-$670.0K	-$420.0K	-$5.170M
YoY Change	-135.08%	-91.88%	202.34%
INVESTING ACTIVITIES
Capital Expenditures	-$80.00K	-$80.00K	-$50.00K
YoY Change	-38.46%	60.0%	-66.67%
Acquisitions
YoY Change
Other Investing Activities	-$1.040M	-$810.0K	$4.920M
YoY Change	-56.49%	-116.46%	1487.1%
Cash From Investing Activities	-$1.110M	-$880.0K	$4.860M
YoY Change	-55.95%	-118.11%	2937.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.00K	4.760M	0.000
YoY Change	-99.62%		-100.0%
NET CHANGE
Cash From Operating Activities	-670.0K	-420.0K	-5.170M
Cash From Investing Activities	-1.110M	-880.0K	4.860M
Cash From Financing Activities	10.00K	4.760M	0.000
Net Change In Cash	-1.770M	3.460M	-310.0K
YoY Change	-186.34%	-1216.13%	-79.87%
FREE CASH FLOW
Cash From Operating Activities	-$670.0K	-$420.0K	-$5.170M
Capital Expenditures	-$80.00K	-$80.00K	-$50.00K
Free Cash Flow	-$590.0K	-$340.0K	-$5.120M
YoY Change	-128.92%	-93.36%	228.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	359000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8913000	USD
CY2020Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	737000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10594000	USD
CY2020Q3	clro	Inventory Noncurrent Raw Materials Net Of Reserves InventoryNoncurrentRawMaterialsNetOfReserves	2751000	USD
CY2019Q4	clro	Inventory Noncurrent Raw Materials Net Of Reserves InventoryNoncurrentRawMaterialsNetOfReserves	1915000	USD
CY2019Q3	us-gaap	Inventory Write Down InventoryWriteDown	168000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9564000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28058000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1858000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1858000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1851000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1587000	USD
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements		shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	572845	shares
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	511332	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	55000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-17000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2610000	USD
	clro	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-421000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	3520000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	108000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5058000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-1976000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5992000	USD
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	440000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	937000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	13522000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1682000	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	19000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	464000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	76000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	106000	USD
CY2020Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	440000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	572845	shares
	us-gaap	Operating Lease Expense OperatingLeaseExpense	510000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	69000	USD
CY2020Q3	us-gaap	Inventory Write Down InventoryWriteDown	277000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	20503000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17000215	shares
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1501000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-5005000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	65000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	11000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	17000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4330000	USD
	us-gaap	Gross Profit GrossProfit	8180000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-78000	USD
	us-gaap	Operating Expenses OperatingExpenses	13726000	USD
	us-gaap	Operating Expenses OperatingExpenses	14773000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2098000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	2537000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6358000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6414000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-67000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17000215	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16768088	shares
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4319000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-50000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	235000	USD
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16646323	shares
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1956000	USD
	us-gaap	Interest Expense InterestExpense	325000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11527000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-25000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4322000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4750000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1300000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense		USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4892000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	82000	USD
	clro	Increase Decrease In Net Cash Provided By Used In Operating Activities IncreaseDecreaseInNetCashProvidedByUsedInOperatingActivities	6261000	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q3	clro	Warrant Instrument Convertible Beneficial Conversion Feature WarrantInstrumentConvertibleBeneficialConversionFeature	122000	USD
CY2020Q3	clro	Warrants Carrying Amount WarrantsCarryingAmount	318000	USD
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	2370000	USD
CY2020Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3000000	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	360000	USD
CY2019Q4	clro	Warrants Carrying Amount WarrantsCarryingAmount	318000	USD
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	778000	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	720000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	2222000	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths		USD
CY2020Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	630000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	689000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	273000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	537000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	306000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	594000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	634000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	577000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	534000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2490000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	504000	USD
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.061	pure
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16650725	shares
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1239000	USD
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M18D
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16768088	shares
CY2020Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	175000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	97000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	182000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	610000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		USD
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1920000	USD
	clro	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-973000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Security12b Title Security12bTitle	Common Stock, $0.001
	dei	Document Type DocumentType	10-Q
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Trading Symbol TradingSymbol	clro
	dei	Entity Central Index Key EntityCentralIndexKey	0000840715
	dei	Entity Registrant Name EntityRegistrantName	CLEARONE INC
	dei	Entity Shell Company EntityShellCompany	false
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	clro	Capitalized Patent Defense Costs CapitalizedPatentDefenseCosts	5565000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	863000	USD
CY2020Q3	clro	Working Capital Deficit WorkingCapitalDeficit	15617000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	45984000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2217000	USD
CY2019Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	147000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2598000	USD
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M24D
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	26000	USD
CY2020Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	192000	USD
CY2020Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	5000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	10876000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	446000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1054000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	354000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8344000	USD
CY2020Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	192000	USD
CY2020Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2980000	USD
CY2020Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue		USD
CY2020Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2980000	USD
CY2020Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	5000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1622000	USD
CY2020Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	38000	USD
CY2019Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	4521000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1391000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1610000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost		USD
CY2020Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss		USD
CY2019Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	4543000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue		USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1370000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3013000	USD
CY2020Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	3013000	USD
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	528107	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements		shares
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	561634	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements		shares
CY2020Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7101000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14009000	USD
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18771257	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	561634	shares
CY2019Q4	clro	Inventory Noncurrent Finished Goods Net Of Reserves InventoryNoncurrentFinishedGoodsNetOfReserves	4369000	USD
CY2020Q3	clro	Inventory Noncurrent Finished Goods Net Of Reserves InventoryNoncurrentFinishedGoodsNetOfReserves	3532000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-41000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2667000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	20000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2812000	USD
	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable		USD
	clro	Payments For Proceeds From Intangible Assets PaymentsForProceedsFromIntangibleAssets	140000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1449000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	78000	USD
	clro	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	4764000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2155000	USD
	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	1499000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	11000	USD
	clro	Capitalized Patent Defense Costs CapitalizedPatentDefenseCosts	3371000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-56000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	266000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-29000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	177000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4186000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11211000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2010000	USD
	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt		USD
	us-gaap	Inventory Write Down InventoryWriteDown	537000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1319000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	179000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-14000	USD
	clro	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	417000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	23000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-309000	USD
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Net Income Loss NetIncomeLoss	-5044000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities		USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6274000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1994000	USD
	clro	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants		USD
	clro	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	419000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1484000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3697000	USD
	us-gaap	Interest Paid Net InterestPaidNet	189000	USD
	us-gaap	Interest Paid Net InterestPaidNet		USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-9201000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	985000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
	us-gaap	Interest Expense InterestExpense		USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16635954	shares
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1160000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1249000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	142000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3455000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10537000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6121000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8412000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4475000	USD
	us-gaap	Gross Profit GrossProfit	8976000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	70000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1428000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Net Income Loss NetIncomeLoss	-6423000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1260000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	847000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4932000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6593000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1443000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8314000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	55110000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18494000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2104000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16635954	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1519000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18927000	USD
CY2019Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	58520000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2082000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	25183000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2183000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6249000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2459000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5583000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	506000	USD
CY2019Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	173000	USD
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18771257	shares
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	995000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14009000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4596000	USD
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1184000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	44250000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	44478000	USD
CY2020Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	395000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4614000	USD
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	63348000	USD
CY2020Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1622000	USD
CY2019Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	6284000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2871000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	140000	USD
CY2020Q3	us-gaap	Assets Assets	57772000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4064000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	424000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5468000	USD
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16650725	shares
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2020Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	3474000	USD
CY2020Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	159000	USD
CY2019Q4	us-gaap	Assets Assets	55110000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13883000	USD
CY2019Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2222000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-176000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4355000	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1736000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3205000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	17000	USD
CY2019Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1907000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1623000	USD
CY2019Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1517000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	7838000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57772000	USD
CY2020Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1391000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	10632000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-190000	USD
CY2019Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	3026000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	11441000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3405000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6705000	USD
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18771257	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	511332	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	528107	shares
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	4680000	USD
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3000000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2021000	USD
	clro	Payments For Proceeds From Intangible Assets PaymentsForProceedsFromIntangibleAssets	43000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	22353000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	111000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	9823000	USD

Files In Submission

Name	View Source	Status
0001753926-20-000379-index-headers.html	Edgar Link	pending
0001753926-20-000379-index.html	Edgar Link	pending
0001753926-20-000379.txt	Edgar Link	pending
0001753926-20-000379-xbrl.zip	Edgar Link	pending
clro-20200930.xml	Edgar Link	completed
clro-20200930.xsd	Edgar Link	pending
clro-20200930_cal.xml	Edgar Link	unprocessable
clro-20200930_def.xml	Edgar Link	unprocessable
clro-20200930_lab.xml	Edgar Link	unprocessable
clro-20200930_pre.xml	Edgar Link	unprocessable
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
ex322_4.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MainDocument.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRO
CLEARONE INC Stock $clro

2020 Q4 Form 10-Q Financial Statement

#000175392620000379 Filed on November 16, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRO CLEARONE INC Stock $clro

2020 Q4 Form 10-Q Financial Statement

#000175392620000379 Filed on November 16, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRO
CLEARONE INC Stock $clro